Admission Date:  [**2188-3-27**]              Discharge Date:   [**2188-5-8**]  Date of Birth:  [**2137-9-10**]             Sex:   M  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 148**] Chief Complaint: Fevers  Major Surgical or Invasive Procedure: ERCP Exploratory Laparotomy Revision Roux Limb Entero-enterostomy x 2 Repair of Abdominal Wall, Wound Dehiscence PICC line VAC   History of Present Illness: Mr. [**Known lastname 57203**] is a 50 yo male with metastatic cholangiocarcinoma who p/w fever and elevated bilirubin level.
He took Tylenol and felt better the next day.
Laminectomy secondary to ruptured disc in [**2173**] 2.
Mr. [**Known lastname 57203**] was then transferred to [**Hospital3 14659**] where he underwent en bloc right hepatectomy, cholecystectomy, resection of extrahepatic bile ducts, regional lymph node dissection and Roux-en-Y hepatic jejunostomy.
The procedure was uncomplicated with the exception of a bilateral chylous pleural effusion.
In light of disease recurrence in this young patient, it was decided to proceed with treatment and he was started on a clinical trial 05-349 and received bevacizumab, gemcitabine, and oxaliplatin.
[**2188-4-5**] 04:13AM BLOOD WBC-11.5* RBC-3.41* Hgb-11.2* Hct-34.1* MCV-100* MCH-32.9* MCHC-32.8 RDW-17.7* Plt Ct-470* [**2188-4-7**] 06:00AM BLOOD Glucose-103 UreaN-6 Creat-0.4* Na-133 K-4.1 Cl-102 HCO3-26 AnGap-9 [**2188-4-1**] 05:40AM BLOOD ALT-100* AST-83* AlkPhos-735* TotBili-2.8* [**2188-4-5**] 04:13AM BLOOD Calcium-8.7 Phos-3.4 Mg-1.7 Test                          Result              Reference Range/Units CA [**99**]-9                       4216  H             0-37 SEE NOTE .
ABDOMEN (SUPINE & ERECT)  [**2188-4-30**] 10:42 AM [**Hospital 93**] MEDICAL CONDITION: 50 year old man s/p entero-enterostomy X 2 and s/p wound exploration and re-closure with retention sutures SUPINE AND ERECT ABDOMEN: No abnormally dilated loops of bowel are seen and gas is noted throughout much of the colon with gas and stool in the rectum.
Unchanged appearance of the anterior abdominal wall, with abnormalities related to previous wound dehiscence, and continued evidence of small foci of air, fluid, and abnormally enhancing tissue, which may represent inflammatory change or, possibly, metastatic seeding of incision tract.
No clear evidence of adhesion of bowel to anterior abdominal wall, as clinically questioned.
Cannot confirm that the anterior peritoneal wall is intact in this patient with history of wound dehiscence and subsequent repair.
-f/u abd CT (RUQ unlikely useful d/t anatomy) -contact GI/ERCP for possible stent placement -blood cultures x 2 .
2) Metastatic cholangiocarcinoma: He is currently enrolled in Phase II trial of Gemcitabine, Oxaliplatin in combination with Bevacizumab, protocol #05-349.
- Hold further chemotherapy until acute illness resolved - Anti-emetics PRN .
3) Pain control: Continue his current regimen of Oxycontin 30 mg qAM.
Will discontinue PRN vicodin given the acetaminophen component in the setting of elevated transaminases.
= = = = = = = = = = = = = = = = = = = = ================================================================ He was admitted to surgery after an ERCP in which they were unable to relieve obstruction with stent placement.
Revision of Roux-en-Y anastomosis with 2     enteroenterostomies.
Pain:He had a PCA and epidural for pain control and was having much pain.
Pain control continued to be an issue and it took some time to wean him from his PCA.
Motrin 800mg q6h was also added.
We consulted Chronic Pain and we added Tizantidine 4 tid and then transitioned him to PO Dilaudid.
On Friday evening, he began gushing salmon colored fluid from his drain and required take back to the OR on [**4-5**] for wound exploration and re-closure with retention sutures.
His abdomen was C/D/I with retention sutures in place.
His drain was D/C on POD [**7-30**].
He continued to drain from the drain site and an ostomy appliance was attached.
His staple line was intact, with a minimal amount of spotty drainage at the midpoint.
His Abd wound explored at bedside, salmon-colored fluid draining.
He was transferred to the the ICU and was placed on a 100% non-rebreather facemask.
The wound was held together with retention sutures and several staples were removed and the site was packed with gauze.
He remained intubated for several days.
Micro: [**4-16**] Abd wound: coag neg staph - sparse; ANAEROBIC: BACTEROIDES FRAGILIS - mod, beta lact positive 5/26,[**4-21**] Sput: sparse yeast [**4-24**]: Extubated, 6  [**4-18**]: Bronched; hypotension responsive to fluid boluses (x2) [**4-20**]: tube feeds started, JP fluid replaced 1/2 cc:cc [**4-23**]: TF w/ 1.5g protein, 30 kcal/kg; TPN stopped [**4-24**] Extubated [**4-25**] : passed speech and swallow  He remained in the ICU for several days and made it out to the floor on [**2188-4-27**].
He was being treated with Fentanyl patch, Dilaudid, Tizanidine, Neurontin.
He was made NPO and started on IVF.
He received a suppository for a post-op Ileus.
He was kept NPO for 2 days and then restarted on a diet.
He was started on TPN and this was then cycled.
A wound VAC was placed on his abdomen and was helping to keep him dry.
He will require VAC change q2d.
VAC changes required Aquacell dressing under each retention suture, Adaptic dressing covering each retention suture, Adaptic dressing within the opening against the fascia, stoma adhesive around the inferior midline  site and around the drain site in the LLQ.
Hypovolemia: He was requiring Albumin for low vascular volume and for his ascities.
Medications on Admission: OxyContin 30 mg PO qAM Vicodin [**11-27**] pills every 4 hours as needed for pain Ativan .5 mg take every 4-6 hours PRN nausea Compazine 10 mg take every 6-8 hours PRN nausea Zofran 8 mg twice a day as necessary PRN nausea Protonix 40 mg every day Norvasc 10 mg every day Emend 125 mg Day 1 of chemo, Day 2 80 mg ,Day 3 80 mg Decadron 8 mg twice a day starting Day 2 after chemo to Day 5  Discharge Medications: 1.
Docusate Sodium 100 mg Capsule [**Month/Day (2) **]: One (1) Capsule PO BID (2 times a day).
Tizanidine 2 mg Tablet [**Month/Day (2) **]: Two (2) Tablet PO TID (3 times a day).
Senna 8.6 mg Tablet [**Month/Day (2) **]: One (1) Tablet PO BID (2 times a day) as needed for constipation.
Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated [**Month/Day (2) **]: One (1) Adhesive Patch, Medicated Topical HS (at bedtime): Apply to Intact Skin.
Mirtazapine 15 mg Tablet [**Month/Day (2) **]: One (1) Tablet PO HS (at bedtime) as needed for insomnia.
Acetaminophen 325 mg Tablet [**Month/Day (2) **]: 1-2 Tablets PO Q6H (every 6 hours) as needed for fever.
Metoprolol Tartrate 25 mg Tablet [**Month/Day (2) **]: 0.5 Tablet PO TID (3 times a day).
Lansoprazole 30 mg Tablet,Rapid Dissolve, DR [**Last Name (STitle) **]: One (1) Tablet,Rapid Dissolve, DR [**Last Name (STitle) **] DAILY (Daily).
Ferrous Sulfate 325 (65) mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO DAILY (Daily).
Gabapentin 250 mg/5 mL Solution [**Last Name (STitle) **]: Ten (10) mL PO Q8H (every 8 hours).
Prochlorperazine 10 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO Q6H (every 6 hours) as needed.
Metoclopramide 10 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO QIDACHS (4 times a day (before meals and at bedtime)).
Bisacodyl 10 mg Suppository [**Last Name (STitle) **]: One (1) Suppository Rectal HS (at bedtime) as needed.
Fentanyl 100 mcg/hr Patch 72 hr [**Last Name (STitle) **]: Two (2)  Transdermal Q72H (every 72 hours).
Spironolactone 25 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO DAILY (Daily).
Simethicone 80 mg Tablet, Chewable [**Last Name (STitle) **]: One (1) Tablet, Chewable PO QID (4 times a day) as needed for Gas.
Heparin Lock Flush (Porcine) 100 unit/mL Syringe [**Last Name (STitle) **]: Two (2) ML Intravenous DAILY (Daily) as needed: After TPN and when Hep locking.
Sodium Chloride 0.9 % 0.9 % Syringe [**Last Name (STitle) **]: Ten (10) mL Injection four times a day: Before and After meds and TPN.
PICC PICC line care per protocol   Discharge Disposition: Home With Service  Facility: VNS of RI  Discharge Diagnosis: Obstructed Roux Limb Wound Dehiscence Metastatic cholangioCA hypoxia/tachycardia.
